US Broker Ratings

Exxon Mobil Corporation (XOM) Stock Analysis: Evaluating the Energy Giant Amid Market Volatility

Exxon Mobil Corporation (NYSE: XOM), a stalwart in the energy sector and one of the world’s largest publicly traded companies, continues to be a focal point for investors looking to..

MiMedx Group, Inc. (MDXG) Investor Outlook: A High Potential Upside of 114% Beckons

MiMedx Group, Inc. (NASDAQ: MDXG) stands as a compelling opportunity for investors with a keen eye on the healthcare sector. Positioned within the biotechnology industry, this U.S.-based company, with a..

Harrow, Inc. (HROW) Stock Analysis: Eye on Nearly 100% Upside with Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector should consider Harrow, Inc. (NASDAQ: HROW), a key player in the niche market of ophthalmic pharmaceuticals. With a market capitalization of..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Eyeing a 163% Potential Upside in the Biotech Sector

Ocular Therapeutix, Inc. (NASDAQ: OCUL) presents an intriguing opportunity for investors in the biotechnology sector, with a compelling potential upside of 163.25%. As a company dedicated to developing and commercializing..

Novavax, Inc. (NVAX) Stock Analysis: Potential 30.6% Upside Amid Strong Revenue Growth

Novavax, Inc. (NVAX), a key player in the biotechnology sector, is drawing attention from investors with its notable revenue growth and potential upside. As a company at the forefront of..

10x Genomics, Inc. (TXG)

⚠️ No article content returned.

..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with a 152% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, is capturing attention in the healthcare sector with its innovative approach to RNA medicine. With a market..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 179.85% Potential Upside

MannKind Corporation (NASDAQ: MNKD) is a noteworthy player in the biotech sector, focusing on innovative treatments for chronic diseases. With a robust portfolio that includes solutions for diabetes, pulmonary hypertension,..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Unveiling a 64% Potential Upside

Pulse Biosciences, Inc. (NASDAQ: PLSE) is a compelling player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in the United States, this innovative company is..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech with a Potential 92.80% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is a standout player in the biotechnology industry, with its focus on developing oral small molecule therapeutics aimed at treating chronic diseases that have significant..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 66% Potential Upside in the Healthcare Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is attracting significant investor attention with a promising potential upside of 66.06%. Based in Fort..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 50.96% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) presents a compelling opportunity for investors, with a potential upside of 50.96% based on current analyst target projections. This biopharmaceutical company, headquartered in Rancho Cucamonga,..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Examining a 26.44% Potential Upside in the Healthcare Sector

GoodRx Holdings, Inc. (NASDAQ: GDRX), a key player in the Health Information Services industry, presents a unique investment opportunity with a compelling potential upside of 26.44%, as indicated by the..

Evolent Health, Inc. (EVH) Stock Analysis: A Compelling 70% Upside Potential in the Healthcare Sector

Evolent Health, Inc. (EVH), a notable player in the healthcare sector specializing in health information services, is capturing the attention of individual investors with its remarkable potential for upside. Trading..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring Growth Potential with a 2.31% Upside

Select Medical Holdings Corporation (NYSE: SEM) presents an intriguing opportunity for investors seeking exposure to the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 16% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a key player in the medical care facilities industry, offers investors an intriguing proposition with its unique blend of service offerings and substantial market..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Steady Growth in Rare Disease Focus Amidst Analyst Hold Ratings

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a prominent player in the biotechnology sector, continues to gain attention with its robust pipeline aimed at treating rare diseases. Headquartered in Princeton, New Jersey,..

agilon health, inc. (AGL) Stock Analysis: Is a 57% Upside Worth the Risks?

In the ever-evolving landscape of healthcare, agilon health, inc. (NYSE: AGL) offers a unique value proposition. Based in Westerville, Ohio, agilon health specializes in providing comprehensive healthcare solutions for seniors..

Mineralys Therapeutics, Inc. (MLYS): Analyst Ratings Signal 86.77% Potential Upside for Biotech Innovator

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a dynamic player in the biotechnology sector, is capturing investor attention with a promising potential upside of 86.77%, as per recent analyst ratings. With a..

Ligand Pharmaceuticals (LGND) Stock Analysis: Exploring a 17.48% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is making waves in the biotechnology sector, capturing the attention of investors with its promising financial outlook and robust product portfolio. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds